Stocks of Research Tools, MDx Vendors Hit Hard in February | GenomeWeb

NEW YORK (GenomeWeb News) – The stocks of most of the 38 firms that comprise the GenomeWeb Daily News Index fell during the month of February, mirroring a drop for the tech-heavy Nasdaq market.

Overall, only nine of the companies in the Index closed the month up compared to January's close. Orchid Cellmark gained around 30 percent to close at $.70, while other notable gainers included CombiMatrix (+15 percent), Illumina (+15 percent), and Life Technologies (+14 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.